PARIS (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose ...
The Pfizer/BioNTech vaccine has been gaining popularity in France – Copyright AFP Wojtek RADWANSKI French media and social networks were abuzz Tuesday with ...
With U.S. syphilis cases on the rise and Pfizer’s Bicillin treatment still in short supply, France’s Laboratoires Delbert is stepping in to help with temporary imports. The French drugmaker is working ...
Healthcare giants Pfizer Inc (NASDAQ:PFE) and AstraZeneca Plc (NASDAQ:AZN) have investments in France, collectively totaling around $1 billion, bolstering the country’s healthcare sector. Pfizer ...
HAMBURG, GERMANY / ACCESSWIRE / July 10, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(NASDAQ:EVO) (MDAX/TecDAX , ISIN: DE0005664809) today announced it has entered into a multi-year master research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results